about
Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debatePostal survey of physicians and laboratories: practices and perceptions of molecular oncology testingNot so simple: a quasi-experimental study of how researchers adjudicate genetic research resultsWhen research seems like clinical care: a qualitative study of the communication of individual cancer genetic research resultsEarly economic evaluation of emerging health technologies: protocol of a systematic review.Understanding sickle cell carrier status identified through newborn screening: a qualitative study.Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening.Public views on participating in newborn screening using genome sequencingExamining the ethical and social issues of health technology design through the public appraisal of prospective scenarios: a study protocol describing a multimedia-based deliberative method.Economic considerations for health insurance coverage of emerging genetic tests.Health-care providers' views on pursuing reproductive benefit through newborn screening: the case of sickle cell disorders.Understanding the new human genetics: a review of scientific editorials.Incorporating documents into qualitative nursing research.Redefining disease? The nosologic implications of molecular genetic knowledge.Expectations and values about expanded newborn screening: a public engagement study.Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.Ethics in Canadian health technology assessment: a descriptive review.What does it mean to trust a health system? A qualitative study of Canadian health care values.Do canadian researchers and the lay public prioritize biomedical research outcomes equally? A choice experiment.Parents' perspectives on participating in genetic research in autism.Imagining value, imagining users: academic technology transfer for health innovation.Insulin pump use and discontinuation in children and teens: a population-based cohort study in Ontario, Canada.A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis.What is a meaningful result? Disclosing the results of genomic research in autism to research participants.Horizon 2020 and the need to reinvent health technology development.Genomic testing in cancer: patient knowledge, attitudes, and expectations.Does a duty of disclosure foster special treatment of genetic research participants?Citizen expectations of 'academic entrepreneurship' in health research: public science, practical benefit.Managing sickle cell carrier results generated through newborn screening in Ontario: a precedent-setting policy story.The importance of being marginal: Norma Ford Walker and a Canadian school of medical genetics.Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment.'Your true and proper gender': the Barr body as a good enough science of sex.How do values shape technology design? An exploration of what makes the pursuit of health and wealth legitimate in academic spin-offsDecision-making about inherited cancer risk: exploring dimensions of genetic responsibilityPublic involvement and health research system governance: a qualitative studyThe expansion of newborn screening: is reproductive benefit an appropriate pursuit?Gene patents—more evidence needed, but policymakers must actCANADIAN PIONEERS: Remembering Norma Ford WalkerCarrier detection and clinical uncertainty: the case for public health ethicsPublic involvement in health research systems: a governance framework
P50
Q28661760-B9B56FDC-FA39-4FEF-AB9E-123CD9FA0B3CQ30227715-9B977326-A1EA-4900-A9C0-1C3C015B0D59Q30502503-986E12F3-A254-4FEF-BE49-6CD3459335C9Q33320883-2D75A4D9-E3E2-4261-BF0E-CE3EC096BB07Q33968510-5E261B20-04C9-4959-A7D1-4B5256E64FAEQ34328669-CED21381-5D8F-4F7F-B6B8-432E8D2D3B5EQ34329302-A338C4D4-0D48-47AC-AF5C-BB287A8A2A79Q34356757-6E10B15B-3914-41D4-B6D3-3D39AD77FC6DQ34500678-1D807372-2390-4359-AA40-0641DF3C742DQ35559823-3B24CF95-5045-450D-97A1-1C6EA6FF8724Q35899306-7301E8E4-4BB7-49C5-BC7C-DDFE569605BBQ36353006-B36DCDEA-98FB-4F70-8897-BA759C5C325CQ36361951-862BB187-0E31-479C-9EFF-1EC96C2A418DQ36401317-722B8B82-5B99-4924-A8D6-19C930D97055Q37333274-D28FFE74-990A-4539-A3D7-D79D8A4DA2E9Q37585888-A4AB102A-7191-4E91-A85D-3B10451DD976Q37618992-850A76E2-4AAF-48BE-972D-8E926721C410Q39277457-0C1C805F-6645-4056-9EF0-C99059FB67FFQ39464278-578281BF-2139-45AE-B5D1-704FC13843EEQ39588412-943D7A03-CCF6-4C6D-AB46-FF65E016F7F3Q40001148-1C56D2A3-373D-4A37-86DA-77DD0F937C59Q40125542-AB7E5E70-BC40-4C8C-8FD4-BC0AA6101578Q40589718-7D3B17A9-EE35-414D-85C2-76525E41F7B0Q41735077-6AD3C219-B1AE-4E98-9CB3-605499D73469Q45720429-3250F0C0-05A1-4CEB-9A0C-D25BDE1183CEQ47755758-3393AA57-0778-4FBC-81FC-AC814D0CCBD7Q47887697-7F52C96C-7A6F-4004-935D-78B25304A352Q48076527-7EB64E68-5643-4BCA-A2FD-A6C8E9D86CB4Q48288225-60BA06EE-6F78-4F97-A21F-379E1F6C8EF5Q48711655-32A8BF86-8DEA-4C32-BEBB-C763E041C113Q50951381-B8AEFB9D-6C44-4C4D-BB39-B0676C20C62AQ53598949-3976FD18-C81D-437C-A859-EB197DCAF1C0Q57145649-C26C28E6-0CF1-44A2-B6F3-7E06207C32F8Q57155407-4385F666-3566-4639-A025-3164DDDC5DC0Q57166691-5BB91CDF-E428-47F4-94F9-5FA849534AD5Q57238658-4DBDF66D-8586-42E3-8B7B-C9BE84FF357FQ57325231-F8208B65-7222-402E-9CDE-677C3F9E6D03Q57568151-013E4F33-B9E4-4CE1-8BC3-83F3E98A601FQ57651980-356B3239-FC33-4992-A175-DD48BA23BFF0Q57768831-709D241B-E58D-4C7A-87B9-5B907B21E7CD
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fiona Miller
@ast
Fiona Miller
@en
Fiona Miller
@es
Fiona Miller
@nl
Fiona Miller
@sl
type
label
Fiona Miller
@ast
Fiona Miller
@en
Fiona Miller
@es
Fiona Miller
@nl
Fiona Miller
@sl
altLabel
Fiona Alice Miller
@en
prefLabel
Fiona Miller
@ast
Fiona Miller
@en
Fiona Miller
@es
Fiona Miller
@nl
Fiona Miller
@sl
P106
P21
P31
P496
0000-0003-4953-6255